IEQ Capital’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-199,864
Closed -$164K – 2107
2026
Q2
$164K Buy
199,864
+81,314
+69% +$76.8K ﹤0.01% 1869
2026
Q1
$109K Buy
118,550
+79,995
+207% +$96.8K ﹤0.01% 1787
2025
Q4
$49.4K Sell
38,555
-7,989
-17% -$10.7K ﹤0.01% 1805
2025
Q3
$60.5K Buy
46,544
+630
+1% +$825 ﹤0.01% 1788
2025
Q2
$55.1K Sell
45,914
-17,268
-27% -$19.1K ﹤0.01% 1758
2025
Q1
$68.2K Buy
+63,182
New +$88.7K ﹤0.01% 1528

Other funds holding LAB

IEQ Capital's LAB Position: Q3 2026 in Review

IEQ Capital sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 199,864 shares — an estimated $164K sold.

IEQ Capital first reported a position in LAB in Q1 2025 and held it in 6 quarters. The position peaked at $164K in Q2 2026. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • IEQ Capital reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
  • IEQ Capital sold 199,864 Standard BioTools shares in Q3 2026, an estimated $164K.
  • IEQ Capital first reported a position in Standard BioTools in Q1 2025 and held it in 6 quarters.
  • IEQ Capital's Standard BioTools position peaked at $164K in Q2 2026.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.